| 缩写名/全名 |
CLIN PHARM DRUG DEV
Clinical Pharmacology in Drug Development |
||||||||||||||||||||
| ISSN号 | 2160-7648 | ||||||||||||||||||||
| 研究方向 | PHARMACOLOGY & PHARMACY- | ||||||||||||||||||||
| 影响因子 | 2015:1.312, 2016:0.911, 2017:1.375, 2018:2.227, 2019:1.903, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||
| 年文章数 | 104 | ||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||
| 投稿链接 | http://mc.manuscriptcentral.com/cpd | ||||||||||||||||||||
| 投稿官网 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2160-7648 | ||||||||||||||||||||
| h-index | 16 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2160-7648%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover Study. Author: Chen J1, Zhuang J1, Wu J2, Chen X3, Wang X1, Huang L1, Zeng G1, Chen J2, Liao X2, Chen X2, Ma Z2, Zhong G1, Huang M1, Zhong D3, Zhao X1. Journal: Clin Pharmacol Drug Dev. 2019 Feb;8(2):217-222. doi: 10.1002/cpdd.450. Epub 2018 Apr 16. PubMed DOI |
| 2. | A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15-mg Tylerdipine Tablet in Healthy Chinese Male Volunteers. Author: Wang L1, Xie L1, Zhou S1, Wang Y1, Chen J1, Zhou Y2, Liu Y1, Zhang H1, Tao M1, Ou N1, Shao F1. Journal: Clin Pharmacol Drug Dev. 2019 Jan;8(1):126-132. doi: 10.1002/cpdd.622. Epub 2018 Oct 10. PubMed DOI |
| 3. | Study on Drug-Drug Interactions Between Chiglitazar, a Novel PPAR Pan-Agonist, and Metformin Hydrochloride in Healthy Subjects. Author: Yi L1,2, Zhang H1,2, Zhang JW3, You XM1,2, Ning ZQ3, Yu J3, Qian LF1,2, Miao LY1,2. Journal: Clin Pharmacol Drug Dev. 2019 Feb 27. doi: 10.1002/cpdd.668. [Epub ahead of print] PubMed DOI |
| 4. | A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects. Author: Han K1, Cremer J2, Elston R3, Oliver S4, Baptiste-Brown S1, Chen S1, Gardiner D1, Davies M5, Saunders J1, Hamatake R2, Losos J2, Leivers M2, Hood S3, van der Berg F6, Paff M7, Ritter JM8, Theodore D2. Journal: Clin Pharmacol Drug Dev. 2019 Mar 12. doi: 10.1002/cpdd.670. [Epub ahead of print] PubMed DOI |
| 5. | Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects. Author: Shen Z1, Zhu X2, Zhang H2, Chen H2, Niu J2, Chen G2, Li X2, Ding Y2. Journal: Clin Pharmacol Drug Dev. 2019 Mar 22. doi: 10.1002/cpdd.674. [Epub ahead of print] PubMed DOI |
| 6. | Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects. Author: Li Y1, Mu Y2, Shi H3, Liang Y3, Liu Z4, Matschke K5, Hickman A3, Krishna R6, Sahasrabudhe V3. Journal: Clin Pharmacol Drug Dev. 2019 Apr 1. doi: 10.1002/cpdd.686. [Epub ahead of print] PubMed DOI |
| 7. | Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers. Author: Zhang SH1,2,3, Li Y1,2, Wei SS1,2,3, Guo L1,2, Huang XM4, Chen Y1,2,3, Wu XX1,2, Cai HL1,2,3, Zhang BK1,2,3. Journal: Clin Pharmacol Drug Dev. 2019 May 6. doi: 10.1002/cpdd.696. [Epub ahead of print] PubMed DOI |
| 8. | Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries. Author: Chitnis SD, Han Y, Yamaguchi M, Mita S, Zhao R, Sunkara G, Kulmatycki K. Journal: Clin Pharmacol Drug Dev. 2016 Jan;5(1):40-51. doi: 10.1002/cpdd.191. Epub 2015 May 15. PubMed |
| 9. | Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation. Author: Bende G, Biswal S, Bhad P, Chen Y, Salunke A, Winter S, Wagner R, Sunkara G. Journal: Clin Pharmacol Drug Dev. 2016 Jan;5(1):76-82. doi: 10.1002/cpdd.215. Epub 2015 Oct 5. PubMed |
|
|
